Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

Update Il y a 4 ans
Reference: NCT02101190

Woman and Man

Extract

The purpose of this study is to assess the pharmacokinetics (PK) of BIA 9-1067 in patients with moderate chronic hepatic impairment and in matched healthy subjects.


Inclusion criteria

  • Parkinson's disease

Links